Does the Mediterranean Diet Have Any Effect on Lipid Profile, Central Obesity and Liver Enzymes in Non-Alcoholic Fatty Liver Disease (NAFLD) Subjects? A Systematic Review and Meta-Analysis of Randomized Control Trials
Open accessThe DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Abstract
The effectiveness of the Mediterranean diet (MD) in non-alcoholic fatty liver disease (NAFLD) subjects has been evaluated in several randomized controlled trials (RCTs). This systematic review and meta-analysis aimed to evaluate the overall effects of MD intervention in a cohort of NAFLD patients targeting specific markers such as central obesity, lipid profile, liver enzymes and fibrosis, and intrahepatic fat (IHF). Google Scholar, PubMed, and Scopus were explored to collect relevant studies from the last 10 years. RCTs with NAFLD subjects were included in this systematic review with a mean intervention duration from 6 weeks to 1 year, and different intervention strategies, mainly including energy restriction MD (normal or low glycaemic index), low-fat MD with increased monounsaturated and polyunsaturated fatty acids, and increased exercise expenditure. The outcomes measured in this meta-analysis were gamma-glutamyl transferase (GGT), alanine aminotransferase (ALT), total cholesterol (TC), waist circumference (WC), and liver fibrosis. Ten randomized controlled trials, which involved a total of 737 adults with NAFLD, were included. According to the results, the MD seems to decrease the liver stiffness (kPa) by –0.42 (CI95% –0.92, 0.09) (p = 0.10) and significantly reduce the TC by –0.46 mg/dl (CI95% –0.55, −0.38) (p = 0.001), while no significant findings were documented for liver enzymes and WC among patients with NAFLD. In conclusion, the MD might reduce indirect and direct outcomes linked with NAFLD severity, such as TC, liver fibrosis, and WC, although it is important to consider the variations across trials. Further RCTs are necessary to corroborate the findings obtained and provide further evidence on the role of the MD in the modulation of other disorders related to NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Effect of MD on ALT [39,40,41,44,45,46].](https://figures.cochat.ai/paper-figures/74a3df0353424b4192e19b8d2e03beb7/does-the-mediterranean-diet-have-any-effect-on-lipid-profile-central-obesity-and-figure-2.jpg)
![Figure 3 The effect of the MD on GGT [39,40,41,44,45].](https://figures.cochat.ai/paper-figures/d2edf81c83d94973a3aa08511a275678/does-the-mediterranean-diet-have-any-effect-on-lipid-profile-central-obesity-and-figure-3.jpg)
![Figure 4 The effect of the MD on liver stiffness [39,40,41,44].](https://figures.cochat.ai/paper-figures/bad38037007f4d948f588a01e100db54/does-the-mediterranean-diet-have-any-effect-on-lipid-profile-central-obesity-and-figure-4.jpg)
![Figure 5 The effect of the MD on TC [39,40,42,44,45,48].](https://figures.cochat.ai/paper-figures/4459a84732404d349036a779be5f4254/does-the-mediterranean-diet-have-any-effect-on-lipid-profile-central-obesity-and-figure-5.jpg)
![Figure 6 The effect of the MD on WC. Abbreviations: SD: standard deviation; mean: mean difference changes pre-post [39,40,41,44,45,46,48].](https://figures.cochat.ai/paper-figures/3d05db80ae234019997fb44af5bef4da/does-the-mediterranean-diet-have-any-effect-on-lipid-profile-central-obesity-and-figure-6.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“While Del Bo et al. [15] found no significant effect of the MD on WC and the level of liver enzymes including ALT, and GGT in MASLD patients.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Estruch, R., Martínez-González, M. A., Corella, D., Salas-Salvadó, J., Fitó, M., Chiva-Blanch, G., Fiol, M., Gómez-Gracia, E., Arós, F., Lapetra, J., et al. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30085-7 · Cited by 195
RetractedEstruch, R., Martínez-González, M. A., Corella, D., Salas-Salvadó, J., Fitó, M., Chiva-Blanch, G., Fiol, M., Gómez-Gracia, E., Arós, F., Lapetra, J., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30074-9 · Cited by 147
RetractedThe PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239 · cited 1×
“Apart from the direct causes of it, NAFLD can also be caused by secondary causes such as the use of steatogenic medication for lengthy periods, in addition to genetic influences [5].”
BackgroundGlobal burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604 · cited 3×
“SFA may promote cellular dysfunction by activating ER stress pathways, upregulating NAFLD-associated pathways, and both systemic and hepatic insulin resistance, as well as contributing to the intrahepatic triglyceride (IHTG) pool [69,70].”
BackgroundByrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,042
Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Younossi, Z., Tacke, F., Arrese, M., Chander Sharma, B., Mostafa, I., Bugianesi, E., Wai‐Sun Wong, V., Yilmaz, Y., George, J., Fan, J., et al. (2019) · Hepatology · doi:10.1002/hep.30251 · Cited by 1,858 · cited 1×
“It is also reported to affect about 25% of the world’s population [4].”
Background
Cited by
Eslam, M., Fan, J.-G., Yu, M.-L., Wong, V. W.-S., Cua, I. H., Liu, C.-J., Tanwandee, T., Gani, R., Seto, W.-K., Alam, S., et al. (2025) · Hepatology International · doi:10.1007/s12072-024-10774-3 · Cited by 170
Fan, J., Xu, X., Yang, R.-X., Nan, Y., Wei, L., Jia, J., Zhuang, H., Shi, J., Li, X., Cm, S., et al. (2024) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2024.00311 · Cited by 153
Panganiban, J. A., Kehar, M., Ibrahim, S. H., Hartmann, P., Sood, S., Hassan, S. M., Ramirez, C. M., Kohli, R., Censani, M., Mauney, E. E., et al. (2025) · Obesity Pillars · doi:10.1016/j.obpill.2025.100164 · Cited by 73
“There are several adult RCT that show improved intrahepatic fat, liver stiffness, liver enzymes, both on TE and US [83 – 87].”
Hamamah, S., Iatcu, O. C., & Covașă, M. (2024) · Nutrients · doi:10.3390/nu17010143 · Cited by 58
Arita, V. A., Cabezas, M. C., Hernández Vargas, J. A., Trujillo-Cáceres, S. J., Mendez Pernicone, N., Bridge, L. A., Raeisi-Dehkordi, H., Dietvorst, C. A. W., Dekker, R., Uriza-Pinzón, J. P., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04320-7 · Cited by 43
Tsitsou, S., Bali, T., Adamantou, M., Saridaki, A., Poulia, K., Karagiannakis, D. S., Papakonstantinou, E., & Cholongitas, Ε. (2025) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70044 · Cited by 45
Ali, H., Shahzil, M., Moond, V., Shahzad, M., Thandavaram, A., Sehar, A., Waseem, H., Siddiqui, T. A., Dahiya, D. S., Patel, P., et al. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14010061 · Cited by 46
“Consequently, the KD is being considered to be a potential treatment for individuals with sarcopenic obesity due to its beneficial impacts on visceral adipose tissue (VAT), adipose tissue regulation, inflammatory markers including cytokines, blood biochemistry, gut microbiota, and overall body…”
BackgroundNAFLD in the 21st Century: Current Knowledge Regarding Its Pathogenesis, Diagnosis and Therapeutics
Kounatidis, D. C., Vallianou, N. G., Geladari, E. V., Panoilia, M.-P., Daskou, A., Stratigou, T., Karampela, Ι., Tsilingiris, D., & Dalamaga, Μ. (2024) · Biomedicines · doi:10.3390/biomedicines12040826 · Cited by 40
“Meta-analyses of randomized control trials (RCTs) have shown that the Mediterranean diet may reduce indirect and direct outcomes associated with NAFLD severity, such as liver fibrosis, total cholesterol, waist circumference, and liver enzymes [75,76].”
Special correlation between diet and MASLD: positive or negative?
Liu, J., Li, C., Yang, Y., Li, J., Sun, X., Zhang, Y., Liu, R., Chen, F., & Li, X. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01382-1 · Cited by 35
Exploring Gender Differences in the Effects of Diet and Physical Activity on Metabolic Parameters
Gorini, S., Camajani, E., Feraco, A., Armani, A., Karav, S., Filardi, T., Aulisa, G., Cava, E., Strollo, R., Padua, E., et al. (2025) · Nutrients · doi:10.3390/nu17020354 · Cited by 29
“The intervention produced greater reductions in TC and LDL-C among men, as well as a marked decrease in ALT [22].”
Njei, B. M., Ameyaw, P. A., Al‐Ajlouni, Y. A., Njei, L., & Boateng, S. (2024) · Cureus · doi:10.7759/cureus.71451 · Cited by 35
“Evidence from systematic reviews and meta-analyses, such as the study by Del Bo' et al., further supports the role of the Mediterranean diet in decreasing total cholesterol and liver fibrosis [73].”
Quetglas‐Llabrés, M. M., Monserrat-Mesquida, M., Bouzas, C., García, S., Argelich, E., Casares, M., Ugarriza, L., Llompart, I., Tur, J. A., & Sureda, A. (2024) · Antioxidants · doi:10.3390/antiox13040480 · Cited by 25
“…and Meta-Analysis of Randomized Control Trials published concludes that the MedDiet’s impact on NAFLD highlights the considerable potential of this dietary pattern in ameliorating parameters associated with NAFLD severity, including improvement in liver function enzymes and NAFLD scores [30].”
BackgroundLiver and obesity: a narrative review
Lonardo, A., & Weiskirchen, R. (2025) · Exploration of Medicine · doi:10.37349/emed.2025.1001334 · Cited by 23
Abdisa, K. B., Szerdahelyi, E., Molnár, M. A., Friedrich, L., Lakner, Z., Koris, A. K., Tóth, A., & Nath, A. (2024) · Biomolecules · doi:10.3390/biom14040478 · Cited by 19
Janota, B., Janion, K., Buzek, A., & Janczewska, E. (2025) · Metabolites · doi:10.3390/metabo15080528 · Cited by 21
“This strategy, within a balanced, minimally processed diet, is a valuable approach to preventing MASLD and its progression to MASH [98,107].”
InfluentialQuetglas‐Llabrés, M. M., Monserrat-Mesquida, M., Bouzas, C., García, S., Mateos, D., Casares, M., Gómez, C., Ugarriza, L., Tur, J. A., & Sureda, A. (2024) · Antioxidants · doi:10.3390/antiox13070754 · Cited by 16
“However, unlike what other studies have shown, the current participants did not reduce hepatic stiffness as other authors have reported after an intervention based on a MedDiet [42].”
Liu, Q., Luan, H., Duan, Z., Ai, J., Wang, Y., & Chen, P. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1660065 · Cited by 16
Scarlata, G. G. M., Lopez, I., Gambardella, M. L., Milanović, M., Milić, N., & Abenavoli, L. (2025) · Molecules · doi:10.3390/molecules30061253 · Cited by 15
“Dietary interventions, particularly those aimed at increasing bioactive compounds, have emerged as promising tools for mitigating the progression of CLDs [6].”
Yameny, A. A. (2025) · Pharaonic Journal of Science · doi:10.71428/pjs.2025.0107 · Cited by 14
Janota, B., & Szymanek, B. (2024) · Cancers · doi:10.3390/cancers16051030 · Cited by 14
“Its adoption contributes to the reduction of inflammation, an improvement to liver stiffness parameters, a reduction in total cholesterol levels, and also a reduction in waist circumference [17,18].”
BackgroundInfluentialAhmed, M., & Ahmed, M. H. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13133893 · Cited by 13
Zhang, X., Ruan, J., He, Y., Xu, A., Fang, Y., Zhang, Q., Gu, L., & Liu, X. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1388557 · Cited by 15
Maćków, M., Dziubyna, T., Jamer, T., Slivinskyi, D., Pytrus, T., Neubauer, K., Zwolinska-Wcislo, M. M., Stawarski, A., Piotrowska, E., & Nowacki, D. (2024) · Nutrients · doi:10.3390/nu16203505 · Cited by 13
Wang, X., Li, S., & Wang, X.-H. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1582861 · Cited by 16
Lin, X., Wang, S., & Huang, J. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1307736 · Cited by 14
Lin, X., Wu, G., & Huang, J. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1315408 · Cited by 14
Keshani, M., Sadeghi, N., Tehrani, S. D., Ahmadi, A. R., & Sharma, M. (2024) · European Journal of Nutrition · doi:10.1007/s00394-024-03478-9 · Cited by 13
Stern, U. M., Wagenpfeil, G., Weber, S. N., Alqahtani, S. A., Michel, M. S., & Schattenberg, J. M. (2026) · European Journal of Nutrition · doi:10.1007/s00394-025-03870-z · Cited by 13
Karjoo, S., Braglia‐Tarpey, A., Chan, A. P., Germán, A. G. A., Herdes, R. E., Pai, N., Velez, D. S., Whitehead, B. A., Quirós‐Tejeira, R. E., & Duro, D. (2025) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/jpn3.70099 · Cited by 9
Li, J., Zhang, Z., Zhang, C., Zhu, Q., Zhao, J., Zong, H., Deng, Q., Zheng, J., Wu, E., Wu, R., et al. (2023) · JMIR Public Health and Surveillance · doi:10.2196/49652 · Cited by 10
“Previous studies indicated that consuming a substantial amount of plant-based foods in the Mediterranean diet may potentially reduce the severity of nonalcoholic fatty liver disease–related outcomes [44] and relate to favorable measures of adiposity [45].”
Kravchuk, S., Bychkov, M. A., Kozyk, M., Strubchevska, O., & Kozyk, A. (2025) · Cureus · doi:10.7759/cureus.84803 · Cited by 20
“The most favorable nutrition pattern for patients with hepatic steatosis, according to numerous scientific studies, is the Mediterranean diet [6,8,10,11].”
Hsieh, M.-L., Su, T., Lin, Y., Chen, Y., Tung, C.-F., Huang, L., Wu, C.-H., Peng, Y., & Hsieh, V. C. (2026) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.70259 · Cited by 10
“A meta-analysis of 10 RCTs also did not detect a significant influence of MD on improving liver stiffness [18].”
Gallegos, I. R., López, P. J. T., Paublini, H., López‐González, Á. A., Sánchez, C. M., Rifá, E. M.-A., & Ramírez‐Manent, J. I. (2025) · Nutrients · doi:10.3390/nu17060945 · Cited by 9
“Previous studies have demonstrated that the MD improves insulin sensitivity [87], reduces visceral fat accumulation [88], and promotes a favorable lipid profile [89], factors that lower the risk of metabolic [90] and cardiovascular diseases [91].”
Moțățăianu, A., Ion, V., Dumitreasă, M., Ormenișan, I., Farczádi, L., Andone, S. R., Bălașa, R., & Roman, M. (2025) · Biomolecules · doi:10.3390/biom15101380 · Cited by 9
Nutrition in MASLD: a patient focused, evidence-based clinician’s guide
Pekarska, K., Brennan, P. N., Wajcman, D. I., Towey, J., Cox, L., Weatherby, K., McPherson, S., Stine, J., Willemse, J., Li, W., et al. (2025) · Frontline Gastroenterology · doi:10.1136/flgastro-2025-103183 · Cited by 8
López‐González, Á. A., Rifá, E. M.-A., Paublini, H., Sánchez, C. M., López, P. J. T., & Ramírez‐Manent, J. I. (2025) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2025.102455 · Cited by 6
Roth, B., D’Amato, M., & Ohlsson, B. (2025) · Nutrition · doi:10.1016/j.nut.2025.112964 · Cited by 4
Zou, J., Tian, F., Cui, S., Hou, J. Y., Li, Z., Wei, Y., Cui, H., Li, Y., Zhou, S., He, Z., et al. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04535-1 · Cited by 4
“…fragmented: most prior studies have restricted their scope to pairwise comparisons of a single diet against a con-trol group or focused primarily on liver enzyme changes, with limited comprehensive assessment of Liver Stiffness Measurement (LSM) and Intrahepatic Lipid (IHL) content [27, 28].”
Mohamadi, B., Ostadan, M. T., Shokri, S., Bakhtiyari, A., Rasooli, R., Sadighara, P., & Bekheir, S. A. (2026) · Toxicology Reports · doi:10.1016/j.toxrep.2026.102216 · Cited by 6
Tosoratto, J., López, P. T., López-González, Á., Paublini-Oliveira, H., Busquets-Cortés, C., & Ramírez-Manent, J. I. (2025) · Diseases · doi:10.3390/diseases13060188 · Cited by 3
“Several studies have consistently demonstrated that adherence to the Mediterranean diet exerts a favorable influence on atherogenic indices, particularly on the triglyceride-to-HDL cholesterol ratio, a key biomarker in cardiovascular risk assessment [68].”
Mokhtari, Z., Abdollahzad, H., Izadi, N., Rezaeian, S., Najafi, F., & Pasdar, Y. (2024) · BMC Public Health · doi:10.1186/s12889-024-20513-w · Cited by 4
“Studies have shown that a reduction in fat and cholesterol consumption leads to a decrease in TC levels [15, 22].”
BackgroundNutritional and Fasting Strategies for the Management of MASLD / MASH : An Integrative Review
Tawk, D., Ghader, G., Khatib, Y., Attieh, P., Youssef, T., Othman, M., Harb, F., Azar, S. T., & Ghadieh, H. E. (2025) · JGH Open · doi:10.1002/jgh3.70315 · Cited by 4
Valenzuela‐Fuenzalida, J. J., Salazar-Arancibia, T., Laborie-Reyes, B., Rodriguez-Ortiz, F., Loaiza-Giraldo, J. P., Salgado, C., Nova-Baeza, P., Orellana-Donoso, M., Moya, M. P., Bruna-Mejías, A., et al. (2026) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2026.105017 · Cited by 3
Sun, L., Chen, H., Ou, Q., Liang, X., Wu, Q., Yu, X., Zhao, H., Huang, Q., Yi, Z., Tan, X., et al. (2023) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2023.104138 · Cited by 3
Association Between Bioimpedance-Determined Metabolic Age and MASLD Risk Scores in Spanish Workers
Gallegos, I. R., Busquets-Cortés, C., Paublini, H., López‐González, Á. A., Rifá, E. M.-A., López, P. J. T., & Ramírez‐Manent, J. I. (2025) · Metabolites · doi:10.3390/metabo15050343 · Cited by 3
“Studies have demonstrated that the Mediterranean diet can decrease hepatic fat accumulation and mitigate MASLD progression [88].”
Sustainability of the Mediterranean Diet: A Nutritional and Environmental Imperative
Micheloni, G., Cocchi, C., Sinigaglia, G., Coppi, F., Zanini, G., Moscucci, F., Sciomer, S., Nasi, M., Desideri, G., Gallina, S., et al. (2025) · Journal of Sustainability Research · doi:10.20900/jsr20250036 · Cited by 13
Al-Qudah, O. M., Alshahwan, H. F., AlSamhori, J. F., Yamin, S., Kaffaf, A., Alassaf, M., & Alwarawrah, Z. (2024) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s481401 · Cited by 2
Sancho, M. E., Ramírez‐Manent, J. I., López, P. J. T., Campayo, I. C., Herrero, M. T. V., & López‐González, Á. A. (2025) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastrohep.2025.502560 · Cited by 2
Alves, S., de Sá, L. M., Agradém, C., Mendes, E., Monteiro, A. M., Fernandes, A., Fernandes, H., Vaz, J. A., & Pereira, A. (2025) · Journal of Ageing and Longevity · doi:10.3390/jal6010005 · Cited by 2
“Antioxidant and anti-inflammatory compounds, particularly olive oil polyphenols and plant flavonoids, further protect HDL functionality and vascular health [56,65,66].”
杜红亚, Feng, Y., Zhou, R., Lei, Y., Deng, B., Ruan, T., Lu, W., & Mu, D. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08233-8 · Cited by 2
“If at least three aspects were rated as low risk, the study was considered high quality, while studies with at least two and one aspect rated as low risk were considered moderate-and low-quality studies, respectively [20].”
Bo, S., Armandi, A., Castelnuovo, G., Goitre, I., Bioletto, F., Guariglia, M., del Campo, N. P. D., Dileo, E., Ponzo, V., Saba, F., et al. (2026) · JHEP Reports · doi:10.1016/j.jhepr.2026.101929 · Cited by 2
Zhu, W. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i2.100243 · Cited by 2
Eganyan, R. A., & Kulikova, M. S. (2024) · Russian Journal of Preventive Medicine · doi:10.17116/profmed202427101131 · Cited by 1
Eganyan, R. A., & Kulikova, M. S. (2025) · Russian Journal of Preventive Medicine · doi:10.17116/profmed202528051117 · Cited by 1
A Gastroenterologist’s Approach to Improving Metabolic Health in MASLD
Razzak, I. A., Razzak, I. A., Noureddin, M., & Trivedi, H. D. (2025) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000002210 · Cited by 1
Zeng, Z., Wei, H., Dong, Y., Sun, S., & Sunu, Z. (2025) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2025.08.004 · Cited by 1
Miano, N., Scilletta, S., Marco, M. D., Capuccio, S., Martedì, M., Coppa, M., Tincu, N., Carasi, S., Ippolito, C., Pistritto, C., et al. (2026) · Nutrients · doi:10.3390/nu18060919 · Cited by 1
“Moreover, data from meta-analyses have shown that the MD is associated with a reduction in total or LDL cholesterol in various clinical settings, such as diabetes and metabolic dysfunction-associated steatotic liver disease [15,16].”
González-Cidad, A., García-Moncó, J. C., & Román, G. C. (2026) · Medicina · doi:10.3390/medicina62040696 · Cited by 1
“The results include reductions in triglycerides and low-density lipoprotein (LDL) cholesterol, along with an increase in beneficial high-density lipoprotein (HDL) cholesterol, as demonstrated by several meta-analyses [24,25].”
Tan, V. M. H., Chiah, G. T. L., Lee, Y., Lim, I. Y., Cheah, M., & Goh, G. B. (2026) · BMC Nutrition · doi:10.1186/s40795-026-01318-z · Cited by 1
Uehara, E., Hokazono, H., & Miura, N. (2025) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v15i1.1529 · Cited by 1
“(TC) levels: Because liver function markers and serum cholesterol levels have been reported to be closely related [24–26], additional exploratory analyses of serum levels of both LDL-c and TC levels were also conducted, although these parameters constituted safety endpoints rather than efficacy…”
Topal, G. G., Sevim, S., Gümüş, D., Balaban, H. Y., Karçaaltıncaba, M., & Kızıl, M. (2024) · PeerJ · doi:10.7717/peerj.17810
Jiang, H., Wu, F., Peng, W., & Wang, C. (2025) · Hepatitis Monthly · doi:10.5812/hepatmon-150630
Mufti, A., Kumala, A. R., Rahayu, I. N., Dagradi, E. M., Husodo, S. D., Dewi, L., Amanda, V. A., & Yuliana, I. S. (2025) · Multidisciplinary Science Journal · doi:10.31893/multiscience.2025503
Research Progress on the Treatment of Non-Alcoholic Fatty Liver Disease with Mediterranean Diet
王, 梓. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1551598 · Cited by 1
Marcos, P. J. T., López‐González, Á. A., Rifá, E. M.-A., Paublini, H., Sánchez, C. M., López, P. J. T., & Ramírez‐Manent, J. I. (2025) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2025.102514
Alhouei, B., & Doaei, S. (2025) · Food Science and Nutrition Cases · doi:10.1079/fsncases.2025.0014
Shi, R., & Joshi, S. (2025) · Nutrition and health · doi:10.1007/978-3-031-87441-3_3
Non-Food Dyslipidemia Factors: Clinical and Metabolic Features and Phenotypic Markers
Usmaev, B. V., Kagermanov, A. T.-A., Shuaipova, M. M., Bestaeva, K. A., Arshieva, V. A., Shahova, A. S., Tsiganock, A. S., Shkhanokova, A. R., & Shadova, S. M. (2025) · Journal Of Biochemical Technology · doi:10.51847/ryngb1tcs0
Martínez‐Sánchez, F. D., Vázquez, S., Gutiérrez-Monterrubio, R., Muñoz, S., & García‐Juárez, I. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i9.110162
Alalwani, J., Derbala, M. F. M., Tayyem, R., & Bassil, M. S. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i11.111995 · Cited by 1
Self-citationWang, Q. J. (2025) · UCL Discovery (University College London)
KAYA, K. L. (2025) · Hasan Kalyoncu University Institutional Repository (Hasan Kalyoncu University)
Dębski, J., Sabuć, A., Spalińska, A., Przybyłowski, J., Skibiak, K., Czerwińska, M., Dzedzej, J., Talarek, E., Gierula, A., Wyszomirski, K., et al. (2026) · Biomedicines · doi:10.3390/biomedicines14030513
“As part of the diet, moderate alcohol con-https sumption is allowed, mainly red wine with meals [23,25].”
FARSHAD, R. K., Akbaş, E., & Öztürk, Y. E. (2026) · British Journal Of Nutrition · doi:10.1017/s0007114526107545
Uzyanbaev, I. A., Timoshenko, S., Спирина, Л. В., & Матвеева, М. В. (2026) · Current Drug Targets · doi:10.2174/0113894501398066251211070417
Özyıldırım, C., Aydemir, M., & Ayhan, N. Y. (2026) · Obesity Medicine · doi:10.1016/j.obmed.2026.100728
Dw, W. (2026) · Theoretical and Natural Science · doi:10.54254/2753-8818/2026.35755
Κοτοπούλη, Β. Σ., & Μάνδυλα, Σ.-Β. Γ. (2026) · University of Thessaly Institutional Repository (University of Thessaly)
The Six Pillars of Lifestyle Medicine in MASLD : An Evidence‐Based Guide
Sharma, J., & Viveiros, K. (2026) · Liver international communications. · doi:10.1002/lci2.70054
Visser, M. E., Gordon, S. L., Brand, A., Schoonees, A., & Naude, C. E. (2026) · Cochrane Evidence Synthesis and Methods · doi:10.1002/cesm.70104
The Mediterranean pyramid: 30 years later, still relevant
Visioli, F., Martínez‐Urbistondo, D., & Martínez‐González, M. Á. (2026) · European Journal of Nutrition · doi:10.1007/s00394-026-04114-4
Kılınç, A., & Akdevelıoğlu, Y. (2026) · British Journal Of Nutrition · doi:10.1017/s0007114526108447
Plečko, S. (2026) · Repository of the University of Primorsk (University of Primorska)
Kianmehr, M., Rafraf, M., Hosseini, A., Kianmehr, M., & Molani‐Gol, R. (2026) · Health Promotion Perspectives · doi:10.34172/hpp.45534
Metadata
- Authors
- Del Bo’, C., Perna, S., Allehdan, S., Rafique, A., Saad, S., AlGhareeb, F., Rondanelli, M., Tayyem, R. F., Marino, M., Martini, D., & Riso, P.
- Affiliations
- Department of Food, Environmental and Nutritional Sciences (DeFENS), Division of Human Nutrition, Università degli Studi di Milano, 20133 Milano, Italy
- University of Milan (IT)
- University of Bahrain (BH)
- University of Pavia (IT)
- Qatar University (QA)
- Corresponding author
- Perna, Simone
- ORCID
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2023-05-09
- Volume
- 15
- Issue
- 10
- Pages
- 2250
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC10222807
- OpenAlex
- W4378515068
- Cited by
- 80
- References
- 101
- Citations by year
- 2026: 18 · 2025: 40 · 2024: 20 · 2023: 2
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Qatar University QSpace (Qatar University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- Mediterranean diet, non-alcoholic fatty liver disease, lipid profile, abdominal obesity, liver enzymes, liver fibrosis, intrahepatic fat, gamma-glutamyl transferase, alanine aminotransferase, total cholesterol, waist circumference, caloric restriction, low-fat diet, monounsaturated fatty acids, polyunsaturated fatty acids, physical activity
- MeSH terms
- Adult, Alanine Transaminase, Humans, Lipids, Liver Cirrhosis, Obesity, Diet, Mediterranean, Obesity, Abdominal, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.